FDA recall record

Hospira 5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count recall — FDA D-0169-2017

Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.

Class IIIclassification
D-0169-2017official record ID
Dec 14, 2016report date

Recall record at a glance

Official recordD-0169-2017
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmHospira Inc.
Report dateDec 14, 2016
Recall initiation dateJun 29, 2016
Quantity287,200 2 mL ampules
LocationLake Forest, IL, United States

Official product description

5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01

Why the product was recalled

Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.

Distribution information

US and Puerto Rico

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.